Approval · Notice of Compliance 3496 · 2003
BAYRAB: Notice of Compliance 3496
Issued December 19, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3496
- Date
- December 19, 2003
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New sterile filling facility
- Therapeutic class
- Passive immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BAYRAB | Not yet assigned | — |
Medicinal ingredients
- RABIES IMMUNOGLOBULIN, HUMAN 150 UNIT per ML